GYN (OVARY) CANCER

Refine Results:
All Categories Epidemiology and Etiology (108) Prevention and Screening (52) Diagnosis and Staging (104) Treatment (186) Supportive Oncology (19)

News

Genentech/Curis Hedgehog Inhibitor Gets Unclear Results in Ovarian Cancer Maintenance Study
The Pink Sheet Daily, 2010 Aug 9, S Haley
Experimental Blood Test Detects BRCA Mutation Carriers
Elsevier Global Medical News, 2010 Jul 16, S Freeman
AMG 386 Takes Antiangiogenesis Therapy in New Direction for Ovarian Cancer
Elsevier Global Medical News, 2010 Jul 14, P Wendling
Pegylated Liposomal Doxorubicin Fails to Best Carboplatin-Paclitaxel in Ovarian Cancer
Elsevier Global Medical News, 2010 Jul 14, P Wendling
Another Phase III Study Supports Avastin Expansion to Ovarian Cancer
The Pink Sheet Daily, 2010 Jul 2, E Hayes
More News ›

Journal Scans

Functional Role and Prognostic Significance of CD157 in Ovarian Carcinoma
J Natl Cancer Inst, 2010 Aug 4, E Ortolan, et al
Trabectedin Plus Pegylated Liposomal Doxorubicin in Relapsed Ovarian Cancer Delays Third-Line Chemotherapy and Prolongs the Platinum-Free Interval
Ann Oncol, 2010 Jul 19, SB Kaye, et al
Ovarian Cancer in the Elderly: Outcomes With Neoadjuvant Chemotherapy or Primary Cytoreduction
Gynecol Oncol, 2010 Jul 1, KA McLean, et al
Independent and Joint Effects of Serum 25-Hydroxyvitamin D and Calcium on Ovarian Cancer Risk: A Prospective Nested Case–Control Study
Eur J Cancer, 2010 Jun 21, AT Toriola, et al
Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
J Clin Oncol, 2010 Jun 14, PA Konstantinopoulos, et al
More Journal Scans ›

Review Articles

Transmission of donor melanoma by organ transplantation
Lancet Oncol, 2010 Aug 1, Dirk C Strauss, et al
Serous Papillary Peritoneal Carcinoma: Unknown Primary Tumour, Ovarian Cancer Counterpart or a Distinct Entity? A Systematic Review
Crit Rev Oncol Hematol, 2010 Jul 1, G Pentheroudakis, et al
EDITORS' PICK
Angioprevention with fenretinide: Targeting angiogenesis in prevention and therapeutic strategies
Crit Rev Oncol Hematol, 2010 Jul 1, Ilaria Sogno, et al
Imaging Ovarian Cancer and Peritoneal Metastases—Current and Emerging Techniques
Nature Reviews Clinical Oncology, 2010 Jul 1, S Kyriazi, et al
EDITORS' PICK
Unmasking the Complexities of Mucinous Ovarian Carcinoma
Gynecol Oncol, 2010 Jun 1, M Frumovitz, et al
EDITORS' PICK
More Review Articles ›

All Journals

Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms
Cancer Lett, 2010 Oct 1, Ingegerd Hellstrom, et al
Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
Cancer Lett, 2010 Sept 1, Yue Wang, et al
Testicular cancer developed in a chronic myeloid leukemia patient with a continued complete cytogenetic and molecular response to imatinib. A case report and review of the literature
Leuk Res, 2010 Sept 1, Dariusz Kata, et al
The ubiquitin–proteasome system is inhibited by p53 protein expression in human ovarian cancer cells
Cancer Lett, 2010 Aug 1, In Young Hwang, et al
Postoperative pain after laparoscopic and vaginal hysterectomy for benign gynecologic disease: a randomized trial
Am J Obstet Gynecol, 2010 Aug 1, Fabio Ghezzi, et al
More All Journals ›

Viewpoints

First Positive Trial of IV Chemotherapy in Ovarian Cancer in 13 Years
Top Stories of 2009, 2010 Jan 1
10 Practice Changes I May Make Based on Presentations at ASCO 2009
2009 Jun 17, Jeffrey Kirshner, et al
Do the Benefits of Breastfeeding Include Protection Against Cancer?
2009 Apr 23, Dave Portnoy, et al
Ovarian Cancer, Silent No More
Community Oncology, 2009 Apr 1, RL Gould
Markman - Superiority of Weekly Paclitaxel Challenges Ovarian Cancer Treatment Paradigm
OncologySTAT One-Year Anniversary Special, 2008 Sept 1
More Viewpoints ›

Chemotherapy Regimens

Topotecan (oral) (Ovary)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel I.V., cisplatin I.V. or I.P., paclitaxel I.P. (Ovary)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel, cisplatin (Ovary)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel, carboplatin (Ovary)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel (Ovary)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
More Chemotherapy Regimens ›

Conference Coverage

Annual Meeting of the Society of Gynecologic Oncologists
March 14-17 2010 San Francisco, et al
SGO 2008 Annual Meeting on Women's Cancer
March 9-12 2008 Tampa FL
The 40th Annual Meeting on Women's Cancer
February 5-8 2009 San Antonio, et al

Videos

Collaboration Aims to Raise Women's Cancer Awareness
ASCO, 2008 May 30, Mary Ellen Schneider

Summary of Key Points

Ovaries and Fallopian Tubes
Abeloff's Clinical Oncology, 4th ed. 2008

Updated Key Points: GYN (Ovary) Cancer

Summary information about GYN (ovary) cancer has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.
Read more ›

When the Smoke Clears

Experts discuss the true clinical implications of watershed developments in oncology research.
Read more ›

Cancer Policy Forum

Behind-the headlines perspectives on health care reform, cancer-related drug legislation, and other topics likely to have a major impact on oncology practice.
Read articles ›

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
    • Forgot your password?
    Not a member? Free registration